On September 25, 2006, the US House of Representatives approved the goals and ideals of a “National Myositis Awareness Day” to be observed on September 21. The proclamation endorsing National…
Continue Reading
FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis
The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of…
Continue Reading
TAP INTO THE POWER OF YOUR MIND
With the right intentions, you can use your mind as a tool to achieve amazing things. You know how sometimes one rotten thing can ruin an otherwise wonderful day? What…
Continue Reading
TMA New Headquarters
In January 2021, we identified a need to address TMA’s occupancy and our desire to be the best stewards of the organization’s resources. In doing so, we found the Headquarters…
Continue Reading
DM Patient Opportunity
Are you an adult (18 years old or older) diagnosed with dermatomyositis (DM)? Modus Outcomes, a patient-centered outcomes research organization, is conducting 60-minute phone interviews with patients with DM to…
Continue Reading